Lymphoma is the most commonly diagnosed cancer in cats and among the most common in dogs. It presents across a wide spectrum — from indolent small cell gastrointestinal lymphoma in cats, where median survival times of 2–4 years are achievable with oral chlorambucil and prednisolone, to high-grade large cell lymphoma in cats and dogs, where aggressive CHOP-based chemotherapy achieves complete remission in 50–70% of cases but median survival of 6–12 months. The range of prognoses and treatment approaches makes lymphoma one of the most emotionally and clinically demanding conditions to manage — and one where structured follow-up between specialist oncology appointments makes a measurable difference to both survival outcomes and owner experience.
Why lymphoma follow-up requires specialist-primary care coordination
Most canine and feline lymphoma is managed at specialist oncology centres, with primary care practices supporting monitoring between treatments. The value of primary care follow-up is specific: watching for early signs of relapse, managing chemotherapy side effects that appear between specialist appointments, monitoring quality of life, and providing the emotional support that keeps owners engaged with a complex treatment protocol.
For cats with small cell (low-grade) gastrointestinal lymphoma — managed with oral chlorambucil and prednisolone at home — primary care follow-up is the entire monitoring system. Cornell University reports that over 90% of cats with small cell lymphoma achieve remission with this protocol, with median survival times of 2–4 years. These cats require regular blood monitoring for chlorambucil side effects (haematological toxicity — neutropenia, thrombocytopenia), clinical assessment of GI signs, and weight monitoring to track remission status. A follow-up call at 2 weeks post-initiation and monthly thereafter provides the owner-side data that complements the laboratory monitoring.
For dogs with high-grade lymphoma on CHOP protocols, the neutrophil nadir between cycles (typically days 5–10 post-treatment) is the highest-risk period. The follow-up framework from the chemotherapy article applies directly. What is specific to lymphoma is remission monitoring — physical examination of peripheral lymph nodes at each appointment, owner observation of swelling or hardness returning in previously reduced nodes, and any return of clinical signs (GI signs, respiratory changes, weight loss).
The lymphoma follow-up timeline
Small cell feline lymphoma (chlorambucil + prednisolone):
| Timepoint | What to check | Red flags |
|---|---|---|
| 2 weeks post-initiation | Clinical improvement in GI signs — vomiting, diarrhoea, appetite; weight stable or improving; chlorambucil being given correctly; any GI side effects | No improvement in clinical signs at 2 weeks — chlorambucil dose may need review; owner not giving medication correctly |
| 4–6 weeks | Haematology (CBC) — neutrophil and platelet count; clinical signs continued improvement; weight; owner confidence in managing medications | Neutropenia or thrombocytopenia — dose reduction or treatment interruption needed; clinical signs worsening — reassess diagnosis or consider treatment modification |
| Every 3 months (stable) | CBC, weight, GI signs, appetite; clinical remission maintained; quality of life assessment | Recurrence of clinical signs — reassess remission status; progressive weight loss |
High-grade canine and feline lymphoma (CHOP-based):
| Timepoint | What to check | Red flags |
|---|---|---|
| Day 5–10 post-each treatment | Neutrophil nadir monitoring — fever, lethargy, anorexia; GI side effects; appetite and energy; lymph node size owner-reported | Fever >39.5°C with lethargy — neutropenic sepsis; significant vomiting or diarrhoea — supportive care needed |
| Between cycles | Lymph node assessment (owner-palpated) — any regrowth? Weight, appetite, energy, quality of life | Any palpable lymph node regrowth — potential early relapse; owner reports significant deterioration in quality of life |
| End of protocol / remission | Physical examination at specialist — lymph node assessment, staging; owner-reported signs; quality of life | Clinical relapse — rescue protocol discussion |
| Every 4–8 weeks post-remission | Owner-reported signs of recurrence — lymph node swelling, GI signs, respiratory changes, lethargy | Suspected relapse — prompt specialist referral |
What to ask owners during lymphoma follow-up
Small cell feline lymphoma:
- Has [cat name]‘s vomiting and diarrhoea improved since starting treatment?
- Is she eating better — has her appetite returned?
- Is she maintaining or gaining weight?
- Are you giving the chlorambucil on the correct schedule — every other day or as prescribed?
- Have you noticed any unusual lethargy, loss of appetite, or bruising that wasn’t there before?
- Do you have your 4–6 week blood test booked?
High-grade lymphoma:
- Have you palpated the lymph nodes this week — do the nodes in the neck, armpits, or groin feel the same size as they did last week?
- Has [pet name] had any fever, weakness, or breathing difficulties since treatment?
- Is appetite and energy level holding up between cycles?
- Have there been any GI side effects — vomiting or diarrhoea?
- How would you describe [pet name]‘s quality of life this week — is she engaging with life, or more withdrawn?
- Do you know the specific signs that would mean you should call us urgently before the next scheduled appointment?
Common lymphoma follow-up mistakes clinics make
Not teaching owners to palpate lymph nodes. Owners of dogs in remission from high-grade lymphoma are the primary early detection system for relapse. A brief demonstration at the end of an appointment showing owners where and how to palpate the submandibular, prescapular, and popliteal lymph nodes — and what a swollen node feels like — gives them a clinically meaningful monitoring tool they can use at home. A follow-up call that asks “have you checked the nodes this week, and do they feel the same size as before?” operationalises this.
Not addressing quality of life proactively. Owners managing a dog or cat through lymphoma treatment are navigating grief, hope, and daily clinical management simultaneously. A follow-up call that includes “how would you describe [pet name]‘s quality of life right now — is she enjoying life?” opens the conversation that owners need to have but rarely initiate. This is one of the most important things primary care can contribute between specialist appointments.
Missing chlorambucil haematological toxicity in small cell lymphoma cats. The oral chlorambucil protocol for feline small cell lymphoma is generally well-tolerated — but bone marrow suppression is a real risk, and haematological monitoring at 4–6 weeks and then every 3 months is the standard of care. A follow-up call that specifically reminds owners of the blood test appointment and asks about any signs of unusual lethargy or bruising keeps this monitoring on schedule.
How to automate lymphoma follow-up without adding to your team’s workload
Nidana Loop schedules a 2-week initiation check for small cell lymphoma cats, with 4–6 week haematology reminders and monthly clinical sign check-ins. For dogs on CHOP, Loop schedules day 5–10 nadir monitoring calls between each cycle. The monthly or bi-monthly owner check-in calls ask specifically about lymph node size, energy, appetite, weight, and quality of life. The clinic sees flags for any case where the owner reports fever, lymph node changes, or significant quality of life decline.
See how Loop handles lymphoma follow-up calls → Book a 20-minute demo
Related: Chemotherapy follow-up · Mast cell tumour follow-up · IBD follow-up in cats